Hallarsis, Bienvinido G.
HRN: 03-89-68 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/08/2023
LEVOFLOXACIN 500MG (TAB)
10/08/2023
10/14/2023
PO
500mg
OD
COPD In AE CAP MR
Checking Final Appropriateness
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes